NAD+ + Sermorelin + Glutathione: The Peptide-Bundle Pricing Comparison

The longevity peptide bundle — NAD+, sermorelin, glutathione — has emerged as a standard men's health add-on. Bundle pricing varies significantly between platforms. Here's how to think about the comparison.

What's in a Standard Bundle

The typical longevity peptide bundle includes: NAD+ (subcutaneous injectable, usually daily or several times weekly), sermorelin (nightly subcutaneous injection, GHRH analog), and glutathione (subcutaneous injectable, daily or several times weekly). Some platforms substitute related peptides — CJC-1295 or ipamorelin instead of sermorelin, for example — or add BPC-157 for tissue repair positioning.

Pricing Structure

Bundle pricing typically falls in a $250-$500/month range at telehealth platforms, though outliers exist in both directions. What drives the range: peptide quantities in each dose, whether all three peptides ship monthly or on staggered cycles, and platform pricing structure (membership + medication vs all-in-one).

Compare pricing on total monthly cost including all peptides, not on advertised per-peptide cost that may exclude some components.

The Individual-Peptide Alternative

Some men prefer to source each peptide individually from separate telehealth platforms or compounding pharmacies rather than a bundle. This can be cheaper per peptide but adds complexity to refill management. If you're on all three long-term, bundle pricing often ends up competitive with individual sourcing once you factor in coordination time.

Cost vs Evidence

Bundle pricing is what it is. What's harder to price is the evidence gap: outcome-level data for these peptides in healthy adults is limited. Men who enroll in bundles should be honest about the difference between "improves biomarkers" and "improves how I feel or function," and should track their own subjective response over 3-6 months to determine whether the spend produces value.

The Evaluation Framework

Before enrolling in a peptide bundle: baseline your relevant biomarkers (IGF-1 for sermorelin response, general metabolic panel), commit to a 3-6 month trial with honest subjective tracking, set a stop-if-no-benefit checkpoint, and don't stack peptides with other simultaneous major life changes that make attribution impossible. Peptides are optimization tools, not treatments for defined conditions in most cases.

Where to Start